Lemaitre Vascular (LMAT) Tops Q2 EPS by 4c

Lemaitre Vascular (NASDAQ: LMAT) reported Q2 EPS of $0.29, $0.04 better than the analyst estimate of $0.25. Revenue for the quarter came in at $42.1 million versus the consensus estimate of $41.39 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• SanDisk upgraded at JPMorgan after investor day; shares climb